Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F. Cravatt, and Jonathan E. Lim on April 10, 2018 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
64
Frequently Asked Questions
What is Market Cap of Boundless Bio Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Boundless Bio Inc. market cap is $27.09M.
What is the 52-week high for Boundless Bio Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Boundless Bio Inc. 52 week high is $3.75 as of October 03, 2025.
What is the 52-week low for Boundless Bio Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Boundless Bio Inc. 52 week low is $1.00 as of October 03, 2025.
What is Boundless Bio Inc. stock price today?
Boundless Bio Inc. stock price today is $1.20.
What was Boundless Bio Inc. stock price yesterday?
Boundless Bio Inc. stock price yesterday was $1.21.
What is the PE ratio of Boundless Bio Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Boundless Bio Inc.’s P/E ratio is -0.42.
What is the Price-to-Book ratio of Boundless Bio Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Boundless Bio Inc. P/B ratio is 0.2208.
What is the 50-day moving average of Boundless Bio Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Boundless Bio Inc. 50-day moving average is $1.16.
